Reader TTS

ABSTRACT Serotonin is a major neurotransmitter in the central nervous system (CNS). Dysregulation of serotonin transmission in the CNS is reported to be related to different psychiatric

disorders in humans including depression, impulsive aggression and anxiety disorders. The most frequently prescribed antidepressants and anxiolytics target the serotonergic system. However,

these drugs are not effective in 20–30% of cases. The causes of this failure as well as the molecular mechanisms involved in the origin of psychological disorders are poorly understood.

Biosynthesis of serotonin in the CNS is initiated by tryptophan hydroxylase 2 (TPH2). In this study, we used _Tph2_-deficient (_Tph2_−/−) mice to evaluate the impact of serotonin depletion

in the brain on mouse behavior. _Tph2_−/− mice exhibited increased depression-like behavior in the forced swim test but not in the tail suspension test. In addition, they showed decreased

anxiety-like behavior in three different paradigms: elevated plus maze, marble burying and novelty-suppressed feeding tests. These phenotypes were accompanied by strong aggressiveness

observed in the resident–intruder paradigm. Despite carrying only one copy of the gene, heterozygous _Tph2_+/− mice showed only 10% reduction in brain serotonin, which was not sufficient to

modulate behavior in the tested paradigms. Our findings provide unequivocal evidence on the pivotal role of central serotonin in anxiety and aggression. SIMILAR CONTENT BEING VIEWED BY

OTHERS DISFUNCTION OF DORSAL RAPHE NUCLEUS-HIPPOCAMPUS SEROTONERGIC-HTR3 TRANSMISSION RESULTS IN ANXIETY PHENOTYPE OF NEUROPLASTIN 65-DEFICIENT MICE Article 25 March 2024 SEROTONERGIC

PSYCHEDELIC 5-MEO-DMT ALTERS PLASTICITY-RELATED GENE EXPRESSION AND GENERATES ANXIOLYTIC EFFECTS IN STRESSED MICE Article 05 July 2024 PKCΔ-POSITIVE GABAERGIC NEURONS IN THE CENTRAL AMYGDALA

EXHIBIT TISSUE-TYPE PLASMINOGEN ACTIVATOR: ROLE IN THE CONTROL OF ANXIETY Article 10 February 2022 INTRODUCTION Serotonin (5-hydroxytryptamine, 5-HT) is a monoamine that has a dual role,

working both as an autacoid in the periphery and as a neurotransmitter in the brain. Synthesis of 5-HT starts with the conversion of the essential amino acid tryptophan (Trp) to

5-hydroxytryptophan (5-HTP) by tryptophan hydroxylase (TPH). In the second step, 5-HTP is decarboxylated to 5-HT by the aromatic amino acid decarboxylase. The discovery of a second _Tph_

gene unraveled the existence of two independent 5-HT systems in vertebrates — peripheral and central — controlled by TPH1 and TPH2, respectively.1, 2 Although TPH1 is mainly expressed in the

gut and is responsible for the synthesis of peripheral serotonin, TPH2 is expressed in the neurons of the raphé nuclei in the brainstem2, 3, 4 and in myenteric neurons in the gut,5 but not

in other peripheral organs such as the lung, heart, kidney or liver.6, 7 Mice lacking TPH2 (_Tph2_−/−, _Tph2_-deficient mice) were recently generated by our group8 and others.3, 9, 10, 11,

12 _Tph2_−/− mice exhibit only minute amounts of brain serotonin, but normal formation and differentiation of serotonergic neurons.3, 8 The level of peripheral serotonin was unchanged in

these mice, although it did not restore the brain 5-HT levels as serotonin cannot cross the blood brain barrier. _Tph2_−/− mice display normal size and no obvious abnormalities at birth, but

exhibit growth retardation during early postnatal life. However, _Tph2_−/− mice catch up the body weight and at the age of 3 months are not any more distinguishable from wild-type mice.

Moreover, these mice exhibit altered thermoregulation and respiratory control, and impaired maternal care.8 It has been postulated that reduction in brain serotonin leads to increased

depressive and aggressive behaviors. In humans different polymorphisms of genes involved in the central serotonin synthesis and transmission are associated with various psychological

abnormalities such as depression,13, 14, 15, 16, 17 anxiety disorders18 and aggression.19, 20 Moreover, differences in the level of serotonin or its metabolite, 5-hydroxyindoleacetic acid

(5-HIAA), in the cerebrospinal fluid have been found in patients with depression21, 22, 23 and destructive behaviors, such as aggression, violence and impulsivity.22, 24, 25, 26 Further

elucidation of mechanisms by which central serotonin is involved in depression and anxiety disorders is required for the improvement of existing medical treatment. In this study, we

evaluated the rate of serotonin synthesis in the central nervous system (CNS) of _Tph2_−/− and _Tph2_-heterozygous (_Tph2_+/−) mice, and investigated the consequence of complete and partial

central serotonin depletion on anxiety, aggression and depression-like behavior. MATERIALS AND METHODS ANIMALS All animal procedures were in accordance with the ethical principles and

guidelines for care and use of laboratory animals adopted by German local authorities corresponding to the standards prescribed by the American Physiological Society. Mice were maintained in

individually ventilated cages, 34 × 19 × 13 cm (Tecniplast Deutschland, Hohenpeissenberg, Germany) under a standard light/dark cycle from 7 am to 7 pm, with free access to standard chow

(0.25% sodium, SSNIFF Spezialitäten, Soest, Germany) and drinking water _ad libitum_. To obtain _Tph2_ gene-deleted mice on a pure genetic background, heterozygous _Tph2_-deficient animals

on C57Bl/6 background (6th generation)8 were bred for further four generations to C57Bl/6 mice (Charles River, Sulzfeld, Germany). All experiments have been performed in adult (18–22 weeks

old) F10 C57Bl/6 _Tph2_−/−, _Tph2_+/− and wild-type (_Tph2_+/+) male mice. To generate animals of the three above-mentioned genotypes _Tph2_+/− females were bred with _Tph2_−/− or _Tph2_+/+

male mice. Genotyping was performed using PCR with primer TPH34 (5′-AGC TGA GGC AGA CAG AAA GG-3′), TPH54 (5′-CCA AAG AGC TAC TCG ACC TAC G-3′) and Neo3 (5′-CTG CGC TGA CAG CCG GAA CAC-3′).

Mice were single housed starting at 10–12 weeks of age as _Tph2_−/− males are highly aggressive and cannot be kept in groups. In order to avoid differences due to single-housing condition

_Tph2_+/− and _Tph2_+/+ were single housed as well at least 4 weeks before experiments. Group-housed (five mice per cage) 23–25 g male mice on FVB/N background were used as intruders in the

resident–intruder paradigm. BEHAVIORAL ASSESSMENT Behavioral testing was performed during the light cycle between 1 and 5 pm, with exception of tail suspension test (TST), which was

performed during the dark cycle. In all experiments mice were habituated at least for one week to the experimental room. During this time handling of animals was done by the same

experimenter who performed the tests. One batch of animals was used for the marble burying test (MBT) and was afterwards tested in the elevated plus maze (EPM) test with a 1 week interval

between the two experiments. Another batch of animals was tested first in the novelty-suppressed feeding test (NSF), and 1 week later in the resident–intruder test (RI). Mice tested first in

the open field were then examined in the forced swim test (FST). For the TST independent cohorts of naïve animals was used. Before, TST mice were kept 9 weeks under reversed dark–light

cycle, with the light off at 10 am. Mouse behavior was video recorded (Panasonic camera HDC TM700, Hamburg, Germany) for subsequent offline analyses by the experimenter. For analysis of EPM

and OF data Biobserve software (Viewer2 version 2.2.0.91, BIOBSERVE GmbH, Bonn, Germany) was used. In MBT, activity was measured by InfraMot (TSE systems, Bad Homburg Germany). In all

experiments, the observer was blinded to the genotype. OPEN FIELD A large arena (50 × 50 cm) under low illumination (30 Lux) was used as an OF to measure locomotor activity. Each mouse was

placed into the arena facing the middle of the wall and its activity was measured during 10 min. The total distance traveled, time spent in the center and near the walls were calculated.

ELEVATED PLUS MAZE The EPM test is based on the inborn aversion of rodents to open, bright illuminated spaces.27 The maze consisted of two open arms (30 × 5 cm) and two closed arms (30 × 5 

cm) that were enclosed by a sidewall on all edges (height 15 cm). Mice were placed in the center of the maze (central platform) facing the closed arm. Total arm entries, percent of entries

into the open arm ((open-arm enteries/total arm enteries) × 100) and time spent in open arms ((open arms/total session duration) × 100) were quantified during 10 min test. Arm entry was only

defined when an animal (the mouse mass center) was at least 3 cm on an arm to differentiate entries from stretched attend postures into the arms. MARBLE-BURYING TEST Marble burying is a

common test for validating anxiolytic effect of drugs.28 The test was conducted in a new cage (equally sized and illuminated as the home cage) with evenly spaced 15 clear glass marbles (20 

mm diameter) in 5 cm of sawdust. During the test mice had access to food and water, and the test cage was covered with a metal grid. After 30 min the test was terminated by removing the

mouse and the number of buried marbles was counted. A marble was scored as buried if more than two-thirds of it was covered with sawdust. During the test locomotor activity was evaluated by

InfraMot (TSE systems). NOVELTY-SUPPRESSED FEEDING This test is based on a provoked conflict between the fear of mice to enter bright illuminated spaces and food seeking induced by

hunger.29, 30 Animals were food deprived 23 h before testing. On the test day after placing mice into a novel home cage for 30 min, they were introduced into a new brightly illuminated test

environment (cage 42 × 25 × 18 cm) where a single food pellet was centrally placed. After the first feeding event animals were returned to their home cages where they were allowed to eat

pre-weighed food over a period of 5 min. Latency to the first eating episode (time between mouse introduction to arena with food pellet in the middle and the first feeding event) was used as

an index of induced anxiety-like behavior. The amount of food consumed in the home cage provided a measure of appetitive drive. FORCED SWIM TEST The FST, as originally described by

Porsolt,31 assesses the tendency to give up attempting to escape from an unpleasant environment, whereby fewer attempts are interpreted as behavioral despair. The apparatus was a plastic

beaker (17.5 cm diameter, 24 cm high), filled with water (24–26 °C) to a height of 18 cm. The time mice spent floating on the water (immobility time, sec) during 6 min as well as latency

(sec) to the first immobility episode were manually observed. A mouse was judged to be immobile when it ceased struggling and remained floating motionless in water, making only those

movements necessary to keep its head above water. Swimming was defined as vigorous movements with forepaws breaking the surface of the water. TAIL SUSPENSION TEST The TST is another learned

helplessness paradigm where animals cannot escape from an unpleasant situation. A reduction in struggling behavior (latency to the first immobile episode or increased total immobility) is

interpreted as a reduction in intrinsic motivation to escape the situation. Mice were suspended by the tail using an adhesive tape to a platform. The latency to the first immobility episode

and the duration of immobility over a 6 min period were continually manually measured. An animal was rated as immobile when there was no movement of the head, extremities or the torso.

RESIDENT–INTRUDER TEST The RI test is based on the territory defensive behavior against unfamiliar intruding conspecifics.32 Each single-housed resident male was confronted in its home cage

by a group-housed (five mice per cage) intruder male FVB/N mouse for 10 min. Each intruder mouse was used only once to avoid submissive/dominance effects after first interaction. Behavioral

interactions during each confrontation were recorded and subsequently scored by an observer. Latency to the first attack, total amount of attacks and cumulative duration of attacks were

analyzed. NEUROCHEMICAL ASSESSMENTS To prepare brains for high-performance liquid chromatography (HPLC) analysis, animals were anesthetized by intraperitoneal ketamine (100 mg kg–1) and

xylazine (10 mg kg–1) injection. Animals were transcardially perfused with phosphate-buffered saline containing 300 U ml–1 heparin (Braun, Melsungen, Germany) to remove the blood, containing

peripheral 5-HT. Brains were removed, weighed and snap-frozen on dry ice. For the determination of serotonin and its metabolites, frozen tissues were homogenized in lysis buffer containing

10 μM ascorbic acid and 1.8% perchloric acid, centrifuged for 30 min at 20 000 _g_, 4 °C, and the supernatant was used for HPLC measurement. Tissue levels of 5-HTP, 5-HT and its metabolite

5-HIAA were analyzed using high sensitive HPLC with fluorometric detection (Shimadzu, Tokyo, Japan).33 Sample separation takes place at 20 °C on a C18 reversed-phase column (OTU LipoMareC18,

AppliChrom Application & Chromatography, Oranienburg, Germany) using a 10 mM potassium phosphate buffer, pH 5.0, containing 5% methanol with a flow rate of 2 ml min–1. Fluorescence of

5-HTP and 5-HT is excited at 295 nm and measured at 345 nm. For the evaluation of serotonin synthesis _in vivo_ animals were injected intraperitoneally with 100 mg kg–1 of aromatic amino

acid decarboxylase inhibitor 3-hydroxybenzylhydrazine dihydrochloride (NSD-1015, CatNr. 54880, Sigma-Aldrich, Munich, Germany) 1 h before brain dissection. Amounts of 5-HT, 5-HTP and 5-HIAA

were normalized to the wet tissue weight for statistical analysis. Calculation of substance levels was based on external standard values. REAL-TIME–PCR ANALYSIS For real-time–PCR (RT–PCR)

analysis animals were first decapitated, and brains were promptly removed and snap-frozen on dry ice. RNA from the whole brain was extracted with Trizol reagent (15596-018 Invitrogen,

Darmstadt, Germany), and residual genomic DNA was removed by DNase I treatment (DNA amplification grade, Sigma-Aldrich). RNA was reverse transcribed using random hexamers and modified

Moloney murine leukemia virus reverse transcriptase (Superscript II, Invitrogen) according to the manufacturer's protocol. RT–PCR was run in a technical triplicate using SYBR green

reagent (Qiagen, Hilden, Germany) in a 384-well plate format (fast RT–PCR system 7900HT, Applied Biosystems, Darmstadt, Germany). The expression of the _Tph2_ gene was quantified using RT2

quantitative PCR primer assay (PPM27894A-200 SABioscience, Hilden, Germany). _Tph2_ expression was normalized to TATA-binding protein (TBP) mRNA expression (primers: forward 5′-CCC TAT CAC

TCC TGC CAC ACC-3′, reverse 5′-CGA AGT GCA ATG GTCTTT AGG TC-3′). The method of Livak and Schmittgen34 was applied to compare gene expression levels between groups, using the equation

2−ΔΔCT. STATISTICS Results are expressed as mean±s.e.m. Statistical analysis was performed by unpaired Student's _t_-test and by one way ANOVA with Bonferroni's correction as a

post-hoc test for multiple comparisons (PRISM, GraphPad, San Diego, CA, USA). _P_<0.05 was considered to be significant. RESULTS _TPH2_ EXPRESSION AND SEROTONIN LEVELS IN _TPH2_−/− MICE

We first evaluated the amount of _Tph2_ transcripts in the brains of _Tph2_+/− and _Tph2_+/+ mice, containing one and two copies of the _Tph2_ gene, respectively. RT–PCR showed a 50%

reduction in _Tph2_ gene expression in the whole brain of _Tph2_+/− mice in comparison with _Tph2_+/+ mice (Figure 1a). We next measured the amount of serotonin and its degradation product,

5-HIAA, in the whole brain of _Tph2_−/−, _Tph2_+/− and _Tph2_+/+ mice by HPLC. _Tph2_−/− mice contained <2% of _Tph2_+/+ 5-HT level and no detectable 5-HIAA in the brain (Figure 1b, Table

1), confirming previous results.8 However, only around 10% reduction in brain serotonin levels was observed in _Tph2_+/− in comparison with _Tph2_+/+ mice, whereas the level of 5-HT

degradation product, 5-HIAA, was reduced nearly by half in _Tph2_+/− (Figure 1b, Table 1). We further evaluated the 5-HT synthesis rate in _Tph2_−/−, _Tph2_+/− and _Tph2_+/+ mice by blocking

conversion of the 5-HTP to 5-HT by the aromatic amino acid decarboxylase inhibitor NSD. An around 20% decrease in accumulation of 5-HTP was observed in _Tph2_+/− in comparison with

_Tph2_+/+ mice (Figure 1c, Table 1). As expected, _Tph2_−/− mice accumulated <2% of 5-HTP compared with _Tph2_+/+ (Figure 1c, Table 1). ANXIETY-LIKE BEHAVIOR IN _TPH2_−/− MICE We first

evaluated overall activity of _Tph2_−/− mice in the OF under low illumination conditions. _Tph2_−/− mice did not show any difference in locomotor activity in comparison with _Tph2_+/− and

_Tph2_+/+ mice (Figure 2a). In EPM, _Tph2_−/− mice spent significantly more time in the open arms than _Tph2_+/+ and _Tph2_+/− (_P_=0.0161 and _P_=0.0133, respectively) (Figure 2c).

_Tph2_−/− mice also exhibited twice the amount of open-arm entries compared with _Tph2_+/+ (_P_=0.0026 vs _Tph2_+/+, _P_=0.0054 vs _Tph2_+/−) (Figure 2d). However, total arm entries and

total distance traveled were comparable between mice of all three genotypes (Figure 2b). Analysis of locomotion in the EPM over time showed that _Tph2_−/− mice extensively explored the

brightest illuminated part of the open arms already during the first 5 min of testing, whereas _Tph2_+/+ animals did not enter the distal parts of the open arms during the whole 10 min of

the test. _Tph2_+/− mice did not show any significant difference compared with _Tph2_+/+ mice neither in the total time spent in open arms nor in the open-arm entries (Figure 2c and d). The

amount of marbles buried by _Tph2_−/− mice in the MBT was significantly lower than that of _Tph2_+/+ and _Tph2_+/− animals (_P_=0.0199 and _P_<0.0001, respectively) (Figure 2e).

Interestingly, the general activity of _Tph2_−/− animals during this test was almost twofold higher than that of _Tph2_+/+ (_P_=0.0046) (Figure 2f). There was no significant difference in

the percentage of marbles buried by _Tph2_+/− mice compared with _Tph2_+/+ mice (Figure 2e). However, _Tph2_+/− showed an intermediate activity, significantly different from both _Tph2_−/−

and _Tph2_+/+ mice (_P_=0.009 and _P_=0.023, respectively) (Figure 2f). In the NSF task, _Tph2_−/− mice needed less time to reach and start eating the food pellet in the center of the arena

compared with _Tph2_+/+ and _Tph2_+/− (_P_=0.002 and _P_=0.017, respectively) (Figure 2g). Food consumption, evaluated during 5 min following the test did not differ between the genotypes

(Figure 2h). _Tph2_+/− mice did not show a significant difference in the latency to reach and start eating the food in comparison with both, _Tph2_+/+ and _Tph2_−/− (Figure 2g and h).

DEPRESSION-LIKE BEHAVIOR IN _TPH2__−/−_ MICE In the FST, _Tph2_+/− mice did not show any significant difference in comparison with _Tph2_+/+ in the total immobility time or the latency to

the first immobility episode, whereas _Tph2_−/− mice demonstrated reduced struggling behavior (Figure 3). They spent less time swimming until the first immobility episode (_P_=0.0001)

(Figure 3a) and stayed longer immobile compared with _Tph2_+/−and _Tph2_+/+ littermates (_P_=0.005, in comparison with both genotypes) (Figure 3b). Moreover, _Tph2_−/− mice showed an

increase in immobility time during each single 2 min episode compared with _Tph2_+/+mice (Figure 3b). In the TST no significant differences between genotypes could be found neither in the

latency to immobility, nor in the struggling time (Figure 3c and d). AGGRESSIVE BEHAVIOR IN _TPH2_−/− MICE In the RI test, _Tph2_−/− mice attacked the intruder almost six times faster than

_Tph2_+/+ mice (_P_=0.0002) (Figure 4a). Furthermore, the number of attacks and the cumulative attack duration in the _Tph2_−/− vs _Tph2_+/+ group were elevated sevenfold (_P_=0.0014 and

_P_=0.01, respectively) (Figure 4b and c). A qualitative analysis of attacks revealed a striking difference between _Tph2_−/− and _Tph2_+/+ mice: within 5 min of the test all mutant animals

displayed aggressive bouts, while only 22% of _Tph2_+/+ mice showed such behavior. Though _Tph2_+/− mice tended to show an intermediate state of aggressive behavior between _Tph2_−/− and

_Tph2_+/+ mice, neither the differences in the first attack latency nor the number of attacks between _Tph2_+/− and _Tph2_+/+ mice were significantly different (Figure 4a and b). DISCUSSION

Although the implication of brain serotonin in animal behavior has been recognized already in the last century, most of the studies were conducted using pharmacological or genetic inhibition

of serotonin reuptake and 5-HT receptors. However, the role of serotonin _per se_ in these studies was not completely clarified, because no suitable animal model was available yet. In this

study, we used mice deficient in brain serotonin synthesis on a pure genetic background to evaluate the consequences of complete absence of this neurotransmitter in the CNS on aggression-,

depression- and anxiety-like behavior. A role of serotonin in the etiology of depressive disorders was suggested more than 50 years ago.35 Later on, formulation of the monoaminergic theory

of depression led to the development of antidepressive drugs, which increase the monoaminergic activity.36 Moreover, severely depressed patients treated with Trp or 5-HTP show symptomatic

improvement,37, 38 whereas, giving Trp-free diet to depressed individuals elicits a relapse in patients getting treatment with antidepressants.39, 40 In our experiments, mice depleted in

brain serotonin exhibited a lack of motivation to struggle in the FST that can be interpreted as a depression-like phenotype, supporting the monoaminergic theory of depression. There is some

discrepancy regarding this phenotype between our results and recent data showing a slight antidepressive effect in _Tph2_−/− mice on the second day of FST.10 These conflicting findings

could be due to several reasons, such as different analysis methods — automated10 vs manual (our study)41 — or the 2-day FST protocol,10 which is commonly used for identifying a depressive

state in rats vs the 1-day protocol usually performed for mice.42, 43 Moreover, the study of depression-like behavior by Savelieva _et al._10 was performed on a mixed genetic background

(C57BL/6Jx129S5/S), that may have masked the behavioral effect of _Tph2_ gene ablation. Evaluation of mouse behavior in another widely used paradigm, the TST, did not reveal a

depression-like phenotype in _Tph2_−/− mice. This finding is consistent with previous studies showing that depletion of serotonin using p-chlorophenylalanine (PCPA) does not change the

outcome of the TST, whereas inhibition of catecholamine synthesis has a prodepressive effect in this test.44 Also in the first description of _Tph2_−/− mice10 no differences in the TST were

observed at the first day of experiment. Interestingly, there are reports that show an increased immobility time in the TST in another genetic model of central serotonin depletion —

heterozygous VMAT2-knockout mice.45 However, in these mice levels of other neurotransmitters are also changed and, therefore, the altered behavior in TST could not be interpreted as only due

to the depletion of central serotonin. Surprisingly, when VMAT2 was ablated only in SERT-positive neurons, the behavior in TST was reversed: VMAT2SERT-Cre mice showed a clear antidepressive

phenotype in the TST.46 However, these animals were on a mixed genetic background that may have veiled the effect of central serotonin ablation. Although both tests, TST and FST, are widely

used for the screening of antidepressants, the validity of these tasks to evaluate symptoms of intrinsic depressive behavior is not so clear.47 Moreover, the sensitivity of these two tests

to pharmacological drugs is not identical, indicating that different neurochemical pathways may mediate the performance in these tasks.48 Additionally, mice being in two different

inescapable situations (wet conditions in FST and dry in TST) could use different strategies to struggle. Accordingly, the direction of alterations in depression-like behavior observed in

several hyposerotonergic models was not consistent across the studies and even controversial between the two tests (TST and FST) in frames of the same study.10, 46, 49 We observed a clear

depression-like phenotype in FST, which was also highly reproducible in our hands—we obtained the same results in two independent experiments (data not shown). However, we could not confirm

the depression-like phenotype of _Tph2_−/− mice in the TST. We cannot exclude that this phenotype was masked due to the performance of the test during the dark cycle. Further studies are

required to clarify the impact of the dark–light cycle on the depression-like behavior in _Tph2_−/− animals. Several previous studies failed to detect any drastic alteration in

depression-like behavior in models of serotonin depletion after PCPA treatment.50, 51, 52 The clear depression-like phenotype observed in the FST in _Tph2_−/− mice can be a consequence of a

life-long depletion in serotonergic transduction vs short-term effects of PCPA. In this respect, it is interesting to note, that mice prenatally exposed to PCPA show increased

depression-related behavior in FST and TST and decreased anxiety.53, 54 Due to the extreme aggressiveness of _Tph2_−/− mice, animals used in our study could not be kept in groups and were

single housed starting 10–12 weeks of age. We can also not exclude that alterations observed in the FST were primed by the prolonged single housing of animals, which may have had more

pronounced consequences in _Tph2_−/− animals owing to their higher sensibility to isolation. In addition, hormonal changes resulting from exaggerated aggressiveness or higher sensitivity to

stress, as well as the reduced fat content in _Tph2_−/− animals 10, 12 (our unpublished data) may have had an impact on the outcome of the FST. As any of the behavior tests used in this

study could be influenced by changed activity, we examined whether _Tph2_−/− mice have any alterations in locomotion. Neither activity in the OF (new environment), nor home cage activity

measured by telemetry recording8 or InfraMot system (TSE Systems GmbH, data not shown) were different between _Tph2_−/− mice and control animals. Serotonin has been postulated to have a role

in aggression.55, 56 Low cerebrospinal 5-HIAA was correlated with elevated aggression in humans26, 57, 58 and monkeys.59 Furthermore, low-Trp diet resulted in increased aggressive behavior

in humans,60 whereas Trp-enriched diet initiated a reduction of physical aggression in subjects that had a history of elevated aggression.61 Several genetic variations in serotonergic genes

have been linked to impulsive aggression in humans.62, 63 Moreover, a positive correlation between low serotonin release and increased aggression was confirmed by microdialysis in freely

moving animals during the RI test.64, 65 Inhibition of serotonin synthesis in rats led to increased aggressiveness, whereas enhancement of serotonin transmission suppressed aggressive

behavior.66 Our study revealed that central serotonin deficiency led to highly increased aggressive behavior in mice. Interestingly, this phenotype was observed not only in males, but also

in _Tph2_−/− females.8 Thus, our model provides strong evidence for increased aggression as a consequence of complete serotonin deficiency in the CNS being in line with two recently

published hyposerotonergic animal models, _TPH2_ R439H knockin mice, bearing a single-nucleotide mutation, equivalent to a rare human variant (R441H) identified in depressed patients,49 and

_Pet-1_ deficient animals, which lack most serotonergic neurons.62, 67 Altogether, these data argue for a direct correlation between the serotonin content in the brain and the level of

aggression. It was recently reported that the absence of brain serotonin leads to increased male–male mounting behavior in a 30 min social interactions task.9 This phenotype was not

prominent during 10 min of the resident–intruder test performed in our study. Moreover, in several cases we had to interrupt the test due to the extreme aggressiveness of _Tph2_−/− animals.

It can not be excluded that defensive behavior of serotonin-deficient animals was misinterpreted in the study of Liu _et al._9 The behavioral evaluation performed in this study showed that

_Tph2_−/− mice have decreased levels of aversive behavior in approach-avoidance-conflict tests, correlating with the hypothesis that enhanced serotonergic transmission in the brain

facilitates anxiety, whereas a decrease in extracellular 5-HT leads to reduced anxious behavior. This hypothesis, formulated in early 1970s68 was further refined using animal models with

5-HT depletion by serotonin synthesis inhibition or lesions of serotonergic neurons.69, 70, 71, 72 Furthermore, studies in SERT overexpressing and SERT-deficient mice,73, 74, 75 in

5-HT1a-deficient animals,76 as well as in very recently published hyposerotonergic mouse models including Lmx1b-, Pet1- or VMAT2-deficient animals46, 77, 78 correlate with this hypothesis.

Despite being in line with the low-anxiety phenotype, observed in the EPM and NSF tests, the results of the MBT poorly correlate with literature data from other genetic models affecting the

serotonergic system.10, 62, 79 We suppose that opposite effects observed in our study originate mostly from the differences in the genetic background (pure C57Bl/6 used by us vs mixed in

other studies)—a factor which may strongly affect serotonin-related behavior, as already shown in SERT-knockout mice.74 On the other hand, the experimental setup used by us was not identical

to the one of other studies: the protocols differ in several aspects, such as amount of marbles, cage parameters and test conditions. Moreover, we cannot exclude that increased locomotion,

unexpectedly observed during MBT and not reported in other studies, had an impact on results of this test in our experiments. There is a vast amount of data about the contribution of

molecular variants of _TPH2_ to psychiatric disorders in humans.15 Interestingly, one single-point mutation (R441H) found in a human cohort of late-onset depression was shown to markedly

decrease activity of TPH2 and central serotonin level.80 A genetic mouse model carrying a single-point mutation (R439H) in _Tph2,_ analogous to this human mutation exhibit significantly

decreased tissue levels and synthesis rates of 5-HT in the brain, and shows pronounced depression-like behavior in TST, as well as increased aggression.49 To check whether reduction in

_Tph2_ gene copy number may also significantly influence behavior in mice, we evaluated the phenotype of _Tph2_+/− animals. Quantification of _Tph2_ mRNA level revealed a decrease in _Tph2_

expression by half, suggesting that in wild-type animals both _Tph2_ alleles are functional and do not undergo epigenetic modification. Regardless, the 50% decrease in _Tph2_ transcriptional

activity, only a 10% reduction in 5-HT level was observed. We missed this difference in our previous study,8 probably because it was masked by the more heterogeneous background of these

animals. Such a slight decrease can be partially explained by a reduced turnover of serotonin by MAO in _Tph2_+/− mice, that is evident from the reduced level of the serotonin degradation

product 5-HIAA (Table 1). However surprisingly, evaluation of 5-HT synthesis rate also revealed only a 20% decrease in _Tph2_+/− animals, which probably reflects the limited availability of

Trp in the brain.81, 82 Nevertheless, the 10% decrease in brain 5-HT was not sufficient to alter mouse behavior: _Tph2_+/− were not different from _Tph2_+/+ mice in aggression, anxiety or

depression-like behavior. Similar effects were recently observed in mice carrying the C1473G mutation in the _Tph2_ gene. This mutation resulted in a decreased 5-HT synthesis rate, but

hardly changed serotonin content in the brain, and did not affect the behavior in depression and anxiety paradigms.83, 84 These findings suggest that a lack of one _Tph2_ allele alone is not

sufficient to modulate aggression and depression-like behavior and therefore is unlikely to be of physiological significance. However, it cannot be excluded that genetic variation in other

serotonin-related genes, restriction or alterations in nutrition, medical treatment and epigenetic modifications acquired during lifespan, may unmask a critical role of _TPH2_

hypo-expression in the development of pathological symptoms in human. Taken together, using _Tph2_−/− mice on a pure genetic background, we provide strong evidence that central serotonin

deficiency leads to exaggerated aggression and decreased anxiety and confirm that our animal model is useful to draw unequivocal conclusions about the physiological significance of this

neurotransmitter. REFERENCES * Walther DJ, Bader M . A unique central tryptophan hydroxylase isoform. _Biochem Pharmacol_ 2003; 66: 1673–1680. Article  CAS  PubMed  Google Scholar  * Walther

DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H _et al_. Synthesis of serotonin by a second tryptophan hydroxylase isoform. _Science_ 2003; 299: 76. Article  CAS  PubMed  Google

Scholar  * Gutknecht L, Waider J, Kraft S, Kriegebaum C, Holtmann B, Reif A _et al_. Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. _J Neural

Transm_ 2008; 115: 1127–1132. Article  CAS  PubMed  Google Scholar  * Patel PD, Pontrello C, Burke S . Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal

gland. _Biol Psychiatry_ 2004; 55: 428–433. Article  CAS  PubMed  Google Scholar  * Neal KB, Parry LJ, Bornstein JC . Strain-specific genetics, anatomy and function of enteric neural

serotonergic pathways in inbred mice. _J Physiol_ 2009; 587: 567–586. Article  CAS  PubMed  Google Scholar  * Zill P, Buttner A, Eisenmenger W, Bondy B, Ackenheil M . Regional mRNA

expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. _Eur Neuropsychopharmacol_ 2004; 14: 282–284. Article  CAS  PubMed  Google Scholar  *

Sakowski SA, Geddes TJ, Thomas DM, Levi E, Hatfield JS, Kuhn DM . Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. _Brain

Res_ 2006; 1085: 11–18. Article  CAS  PubMed  Google Scholar  * Alenina N, Kikic D, Todiras M, Mosienko V, Qadri F, Plehm R _et al_. Growth retardation and altered autonomic control in mice

lacking brain serotonin. _Proc Natl Acad Sci USA_ 2009; 106: 10332–10337. Article  CAS  PubMed  PubMed Central  Google Scholar  * Liu Y, Jiang Y, Si Y, Kim JY, Chen ZF, Rao Y . Molecular

regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice. _Nature_ 2011; 472: 95–99. Article  CAS  PubMed  PubMed Central  Google Scholar  * Savelieva

KV, Zhao S, Pogorelov VM, Rajan I, Yang Q, Cullinan E _et al_. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive

to antidepressants. _PLoS One_ 2008; 3: e3301. Article  CAS  PubMed  PubMed Central  Google Scholar  * Thomas DM, Angoa Perez M, Francescutti-Verbeem DM, Shah MM, Kuhn DM . The role of

endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum. _J Neurochem_ 2010; 115: 595–605. Article  CAS  PubMed  PubMed Central  Google

Scholar  * Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, Confavreux C _et al_. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.

_Cell_ 2009; 138: 976–989. Article  CAS  PubMed  PubMed Central  Google Scholar  * Levinson DF . The genetics of depression: a review. _Biol Psychiatry_ 2006; 60: 84–92. Article  CAS  PubMed

  Google Scholar  * Lohoff FW . Overview of the genetics of major depressive disorder. _Curr Psychiatry Rep_ 2010; 12: 539–546. Article  PubMed  PubMed Central  Google Scholar  * Matthes S,

Mosienko V, Bashammakh S, Alenina N, Bader M . Tryptophan hydroxylase as novel target for the treatment of depressive disorders. _Pharmacology_ 2010; 85: 95–109. Article  CAS  PubMed  Google

Scholar  * Van Den Bogaert A, Sleegers K, De Zutter S, Heyrman L, Norrback KF, Adolfsson R _et al_. Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar

disorder in a Northern Swedish, isolated population. _Arch Gen Psychiatry_ 2006; 63: 1103–1110. Article  CAS  PubMed  Google Scholar  * Zill P, Baghai TC, Zwanzger P, Schule C, Eser D,

Rupprecht R _et al_. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. _Mol Psychiatry_ 2004; 9:

1030–1036. Article  CAS  PubMed  Google Scholar  * Hovatta I, Barlow C . Molecular genetics of anxiety in mice and men. _Ann Med_ 2008; 40: 92–109. Article  CAS  PubMed  Google Scholar  *

Craig IW, Halton KE . Genetics of human aggressive behaviour. _Hum Genet_ 2009; 126: 101–113. Article  PubMed  Google Scholar  * Zalsman G, Patya M, Frisch A, Ofek H, Schapir L, Blum I _et

al_. Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: a multi-center study. _World J Biol Psychiatry_

2011; 12: 33–41. Article  PubMed  Google Scholar  * Gibbons RD, Davis JM . Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels. _Acta

Psychiatr Scand_ 1986; 74: 8–12. Article  CAS  PubMed  Google Scholar  * Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ . Aggressivity, suicide attempts, and depression:

relationship to cerebrospinal fluid monoamine metabolite levels. _Biol Psychiatry_ 2001; 50: 783–791. Article  CAS  PubMed  Google Scholar  * Stanley M, Traskman-Bendz L, Dorovini-Zis K .

Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. _Life Sci_ 1985; 37: 1279–1286. Article  CAS  PubMed  Google Scholar  * Birger M, Swartz M, Cohen

D, Alesh Y, Grishpan C, Kotelr M . Aggression: the testosterone-serotonin link. _Isr Med Assoc J_ 2003; 5: 653–658. CAS  PubMed  Google Scholar  * Brown GL, Linnoila MI . CSF serotonin

metabolite (5-HIAA) studies in depression, impulsivity, and violence. _J Clin Psychiatry_ 1990; 51 Suppl: 31–41, discussion 42–33. PubMed  Google Scholar  * Stanley B, Molcho A, Stanley M,

Winchel R, Gameroff MJ, Parsons B _et al_. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. _Am J Psychiatry_ 2000; 157: 609–614.

Article  CAS  PubMed  Google Scholar  * Pellow S, Chopin P, File SE, Briley M . Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. _J Neurosci

Methods_ 1985; 14: 149–167. Article  CAS  PubMed  Google Scholar  * Njung’e K, Handley SL . Evaluation of marble-burying behavior as a model of anxiety. _Pharmacol Biochem Behav_ 1991; 38:

63–67. Article  PubMed  Google Scholar  * Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH _et al_. Altered depression-related behaviors and functional changes in the dorsal

raphe nucleus of serotonin transporter-deficient mice. _Biol Psychiatry_ 2003; 54: 960–971. Article  CAS  PubMed  Google Scholar  * Bessa JM, Mesquita AR, Oliveira M, Pego JM, Cerqueira JJ,

Palha JA _et al_. A trans-dimensional approach to the behavioral aspects of depression. _Front Behav Neurosci_ 2009; 3: 1. Article  PubMed  PubMed Central  Google Scholar  * Porsolt RD,

Bertin A, Jalfre M . Behavioral despair in mice: a primary screening test for antidepressants. _Arch Int Pharmacodyn Ther_ 1977; 229: 327–336. CAS  PubMed  Google Scholar  * Kulikov AV,

Osipova DV, Naumenko VS, Popova NK . Association between Tph2 gene polymorphism, brain tryptophan hydroxylase activity and aggressiveness in mouse strains. _Genes Brain Behav_ 2005; 4:

482–485. Article  CAS  PubMed  Google Scholar  * Yamaguchi T, Sawada M, Kato T, Nagatsu T . Demonstration of tryptophan 5-monooxygenase activity in human brain by high sensitive

high-performance liquid chromatography with fluorometric detection. _Biochem Int_ 1981; 2: 295–303. CAS  Google Scholar  * Livak KJ, Schmittgen TD . Analysis of relative gene expression data

using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. _Methods_ 2001; 25: 402–408. Article  CAS  PubMed  Google Scholar  * Brodie BB, Pletscher A, Shore PA . Evidence that

serotonin has a role in brain function. _Science_ 1955; 122: 968. Article  CAS  PubMed  Google Scholar  * Lopez-Munoz F, Alamo C . Monoaminergic neurotransmission: the history of the

discovery of antidepressants from 1950s until today. _Curr Pharm Des_ 2009; 15: 1563–1586. Article  CAS  PubMed  Google Scholar  * Price LH, Malison RT, McDougle CJ, Pelton GH, Heninger GR .

The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion. _Biol Psychiatry_ 1998; 43: 339–347. Article  CAS  PubMed  Google Scholar  * van Praag HM

. In search of the mode of action of antidepressants. 5-HTP/tyrosine mixtures in depressions. _Neuropharmacology_ 1983; 22: 433–440. Article  CAS  PubMed  Google Scholar  * Miller HL,

Delgado PL, Salomon RM, Licinio J, Barr LC, Charney DS . Acute tryptophan depletion: a method of studying antidepressant action. _J Clin Psychiatry_ 1992; 53 Suppl: 28–35. PubMed  Google

Scholar  * Schruers K, Griez E . The effects of tryptophan depletion on mood and psychiatric symptoms. _J Affect Disord_ 2003; 74: 305. Article  CAS  PubMed  Google Scholar  * Baker M .

Animal models: inside the minds of mice and men. _Nature_ 2011; 475: 123–128. Article  CAS  PubMed  Google Scholar  * Cryan JF, Mombereau C . In search of a depressed mouse: utility of

models for studying depression-related behavior in genetically modified mice. _Mol Psychiatry_ 2004; 9: 326–357. Article  CAS  PubMed  Google Scholar  * Drugan RC, Morrow AL, Weizman R,

Weizman A, Deutsch SI, Crawley JN _et al_. Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine

receptor occupancy. _Brain Res_ 1989; 487: 45–51. Article  CAS  PubMed  Google Scholar  * O’Leary OF, Bechtholt AJ, Crowley JJ, Valentino RJ, Lucki I . The role of noradrenergic tone in the

dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. _Eur Neuropsychopharmacol_ 2007; 17: 215–226. Article  CAS  PubMed  Google Scholar  * Fukui M,

Rodriguiz RM, Zhou J, Jiang SX, Phillips LE, Caron MG _et al_. Vmat2 heterozygous mutant mice display a depressive-like phenotype. _J Neurosci_ 2007; 27: 10520–10529. Article  CAS  PubMed 

PubMed Central  Google Scholar  * Narboux-Neme N, Sagne C, Doly S, Diaz SL, Martin CB, Angenard G _et al_. Severe serotonin depletion after conditional deletion of the vesicular monoamine

transporter 2 gene in serotonin neurons: neural and behavioral consequences. _Neuropsychopharmacology_ 2011. * Cryan JF, Holmes A . The ascent of mouse: advances in modelling human

depression and anxiety. _Nat Rev Drug Discov_ 2005; 4: 775–790. Article  CAS  PubMed  Google Scholar  * Bai F, Li X, Clay M, Lindstrom T, Skolnick P . Intra- and interstrain differences in

models of “behavioral despair”. _Pharmacol Biochem Behav_ 2001; 70: 187–192. Article  CAS  PubMed  Google Scholar  * Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC _et

al_. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. _Proc Natl Acad Sci USA_ 2008; 105: 1333–1338. Article  CAS  PubMed  PubMed Central  Google Scholar  *

Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S _et al_. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats

and mice. _Naunyn Schmiedebergs Arch Pharmacol_ 2004; 369: 547–553. Article  CAS  PubMed  Google Scholar  * O’Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I . Depletion of

serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. _Psychopharmacology_ 2007; 192: 357–371.

Article  CAS  PubMed  Google Scholar  * Redrobe JP, Bourin M . Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming

test. _Psychopharmacology_ 1998; 138: 198–206. Article  CAS  PubMed  Google Scholar  * Vataeva LA, Kudrin VS, Vershinina EA, Mosin VM, Tiul’kova EI, Otellin VA . Behavioral alteration in

the adult rats prenatally exposed to para-chlorophenylalanine. _Brain Res_ 2007; 1169: 9–16. Article  CAS  PubMed  Google Scholar  * Vataeva LA, Kudrin VS, Vershinina EA, Mosin VM, Tiul’kova

EI, Otellin VA . Maternal para-chlorophenylalanine exposure modifies central monoamines and behaviors in the adult offspring. _Brain Res_ 2008; 1234: 1–7. Article  CAS  PubMed  Google

Scholar  * Maas JW . Neurochemical differences between two strains of mice. _Science_ 1962; 137: 621–622. Article  CAS  PubMed  Google Scholar  * Valzelli L, Giacalone E, Garattini S .

Pharmacological control of aggressive behavior in mice. _Eur J Pharmacol_ 1967; 2: 144–146. Article  CAS  PubMed  Google Scholar  * Coccaro EF . Impulsive aggression and central serotonergic

system function in humans: an example of a dimensional brain-behavior relationship. _Int Clin Psychopharmacol_ 1992; 7: 3–12. Article  CAS  PubMed  Google Scholar  * Coccaro EF, Kavoussi

RJ, Hauger RL . Serotonin function and antiaggressive response to fluoxetine: a pilot study. _Biol Psychiatry_ 1997; 42: 546–552. Article  CAS  PubMed  Google Scholar  * Zajicek KB, Price

CS, Shoaf SE, Mehlman PT, Suomi SJ, Linnoila M _et al_. Seasonal variation in CSF 5-HIAA concentrations in male rhesus macaques. _Neuropsychopharmacology_ 2000; 22: 240–250. Article  CAS 

PubMed  Google Scholar  * Zepf FD, Stadler C, Demisch L, Schmitt M, Landgraf M, Poustka F . Serotonergic functioning and trait-impulsivity in attention-deficit/hyperactivity-disordered boys

(ADHD): influence of rapid tryptophan depletion. _Hum Psychopharmacol_ 2008; 23: 43–51. Article  CAS  PubMed  Google Scholar  * Nantel-Vivier A, Pihl RO, Young SN, Parent S, Belanger SA,

Sutton R _et al_. Serotonergic contribution to boys’ behavioral regulation. _PLoS One_ 2011; 6: e20304. Article  CAS  PubMed  PubMed Central  Google Scholar  * Schaefer TL, Vorhees CV,

Williams MT . Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and

defensiveness. _Neuroscience_ 2009; 164: 1431–1443. Article  CAS  PubMed  Google Scholar  * Heinz AJ, Beck A, Meyer-Lindenberg A, Sterzer P, Heinz A . Cognitive and neurobiological

mechanisms of alcohol-related aggression. _Nat Rev Neurosci_ 2011; 12: 400–413. Article  CAS  PubMed  Google Scholar  * Ferrari PF, van Erp AM, Tornatzky W, Miczek KA . Accumbal dopamine and

serotonin in anticipation of the next aggressive episode in rats. _Eur J Neurosci_ 2003; 17: 371–378. Article  CAS  PubMed  Google Scholar  * van Erp AM, Miczek KA . Aggressive behavior,

increased accumbal dopamine, and decreased cortical serotonin in rats. _J Neurosci_ 2000; 20: 9320–9325. Article  CAS  PubMed  PubMed Central  Google Scholar  * Lucki I . The spectrum of

behaviors influenced by serotonin. _Biol Psychiatry_ 1998; 44: 151–162. Article  CAS  PubMed  Google Scholar  * Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B _et

al_. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. _Neuron_ 2003; 37: 233–247. Article  CAS  PubMed  Google

Scholar  * Wise CD, Berger BD, Stein L . Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. _Science_ 1972; 177: 180–183. Article  CAS  PubMed 

Google Scholar  * Andrade TG, Macedo CE, Zangrossi Jr H, Graeff FG . Anxiolytic-like effects of median raphe nucleus lesion in the elevated T-maze. _Behav Brain Res_ 2004; 153: 55–60.

Article  CAS  PubMed  Google Scholar  * Briley M, Chopin P, Moret C . Effect of serotonergic lesion on “anxious” behaviour measured in the elevated plus-maze test in the rat.

_Psychopharmacology_ 1990; 101: 187–189. Article  CAS  PubMed  Google Scholar  * Critchley MA, Njung’e K, Handley SL . Actions and some interactions of 5-HT1A ligands in the elevated X-maze

and effects of dorsal raphe lesions. _Psychopharmacology_ 1992; 106: 484–490. Article  CAS  PubMed  Google Scholar  * Soderpalm B, Engel JA . Serotonergic involvement in conflict behaviour.

_Eur Neuropsychopharmacol_ 1990; 1: 7–13. Article  CAS  PubMed  Google Scholar  * Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA . Early-life blockade of the 5-HT transporter alters

emotional behavior in adult mice. _Science_ 2004; 306: 879–881. Article  CAS  PubMed  Google Scholar  * Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN . Abnormal anxiety-related behavior in

serotonin transporter null mutant mice: the influence of genetic background. _Genes Brain Behav_ 2003; 2: 365–380. Article  CAS  PubMed  Google Scholar  * Jennings KA, Loder MK, Sheward WJ,

Pei Q, Deacon RM, Benson MA _et al_. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. _J Neurosci_ 2006; 26: 8955–8964.

Article  CAS  PubMed  PubMed Central  Google Scholar  * Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L _et al_. Serotonin1A receptor acts during development to establish normal

anxiety-like behaviour in the adult. _Nature_ 2002; 416: 396–400. Article  CAS  PubMed  Google Scholar  * Dai JX, Han HL, Tian M, Cao J, Xiu JB, Song NN _et al_. Enhanced contextual fear

memory in central serotonin-deficient mice. _Proc Natl Acad Sci USA_ 2008; 105: 11981–11986. Article  CAS  PubMed  PubMed Central  Google Scholar  * Kiyasova V, Fernandez SP, Laine J,

Stankovski L, Muzerelle A, Doly S _et al_. A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei. _J Neurosci_ 2011; 31: 2756–2768.

Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhao S, Edwards J, Carroll J, Wiedholz L, Millstein RA, Jaing C _et al_. Insertion mutation at the C-terminus of the serotonin

transporter disrupts brain serotonin function and emotion-related behaviors in mice. _Neuroscience_ 2006; 140: 321–334. Article  CAS  PubMed  Google Scholar  * Zhang X, Gainetdinov RR,

Beaulieu JM, Sotnikova TD, Burch LH, Williams RB _et al_. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. _Neuron_ 2005; 45: 11–16. Article 

CAS  PubMed  Google Scholar  * Fernstrom JD, Wurtman RJ . Brain serotonin content: physiological dependence on plasma tryptophan levels. _Science_ 1971; 173: 149–152. Article  CAS  PubMed 

Google Scholar  * Markus CR . Dietary amino acids and brain serotonin function; implications for stress-related affective changes. _Neuromolecular Med_ 2008; 10: 247–258. Article  CAS 

PubMed  Google Scholar  * Siesser WB, Zhang X, Jacobsen JP, Sotnikova TD, Gainetdinov RR, Caron MG . Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue

content in C57Bl/6 and BALB/c congenic mice. _Neurosci Lett_ 2010; 481: 6–11. Article  CAS  PubMed  PubMed Central  Google Scholar  * Tenner K, Qadri F, Bert B, Voigt JP, Bader M . The mTPH2

C1473G single nucleotide polymorphism is not responsible for behavioural differences between mouse strains. _Neurosci Lett_ 2008; 431: 21–25. Article  CAS  PubMed  Google Scholar  Download

references ACKNOWLEDGEMENTS This work was supported by a fellowship of the German Academic Exchange Service (DAAD) to VM (A07/99669). We thank Susanne da Costa Goncalves, Sabine Grüger,

Manfred Ströhmann and Alexandra Wistel-Wozniak for the excellent technical assistance, Catherine Schweppe for the critical reading of the manuscript, Babila Tachu and Silke Frahm for the

helpful suggestions in experiment design. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Molecular Biology of Peptide Hormones, Max-Delbrueck-Center for Molecular Medicine,

Berlin, Germany V Mosienko, D Beis, S Matthes, M Bader & N Alenina * Department of Biology, Faculty of Mathematics and Natural Sciences, Humboldt-Universität Berlin, Berlin, Germany V

Mosienko, D Beis & S Matthes * Institute of Pharmacology and Toxicology, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany B Bert & H Fink Authors * V Mosienko

View author publications You can also search for this author inPubMed Google Scholar * B Bert View author publications You can also search for this author inPubMed Google Scholar * D Beis

View author publications You can also search for this author inPubMed Google Scholar * S Matthes View author publications You can also search for this author inPubMed Google Scholar * H Fink

View author publications You can also search for this author inPubMed Google Scholar * M Bader View author publications You can also search for this author inPubMed Google Scholar * N

Alenina View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to N Alenina. ETHICS DECLARATIONS COMPETING INTERESTS The

authors declare no conflict of interest. RIGHTS AND PERMISSIONS This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a

copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Mosienko, V., Bert, B., Beis, D. _et al._

Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. _Transl Psychiatry_ 2, e122 (2012). https://doi.org/10.1038/tp.2012.44 Download citation * Received: 06

April 2012 * Accepted: 11 April 2012 * Published: 29 May 2012 * Issue Date: May 2012 * DOI: https://doi.org/10.1038/tp.2012.44 SHARE THIS ARTICLE Anyone you share the following link with

will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt

content-sharing initiative KEYWORDS * aggression * anxiety * depression * serotonin * tryptophan hydroxylase